Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)
Trial details
- Registry ID
- NCT05854784
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)NCT05854784 | Clinuvel Pharmaceuticals Limited | Phase 2 | Completed | 2023-12-28Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |